What’s next for Walgreens following its private equity sale?

Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs and reduced access to healthcare in vulnerable communities.

Editor's Pick

Top Story What's Next for Walgreens Following its Private Equity Sale? Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs and reduced access to healthcare in vulnerable communities. Sponsored Discover how Mayo Clinic Platform_Solutions Studio can accelerate the commercialization of your digital health solution. Presented by Mayo Clinic Platform_Solutions Studio Whether you're ready to build, validate, or deploy your AI solution into clinical workflows, Solutions Studio offers comprehensive technical and business support tailored to your needs. Learn more. It's Almost Here: The Best Networking - INVEST Digital Health Starts Thursday! Time is almost up to secure your spot at INVEST Digital Health. Join industry leaders for a day of powerful insights, connections, and strategies you can put into action right away. Don't miss your chance to be part of the conversations shaping the future of healthcare. Register Now

Featured News

Maze Therapeutics Drug Shows Potential to Top Asset Acquired by Otsuka for $800M With positive Phase 1 results for the metabolic disorder drug MZE782, Maze Therapeutics plans to advance the small molecule to Phase 2 tests in phenylketonuria and chronic kidney disease. Following the data readout, Maze raised $150 million in a private placement. Industry Groups Warn CMS' 2026 Fee Schedule Could Undermine Value-Based Care Healthcare groups are pushing back on CMS' proposed physician fee schedule for next year, raising concerns over payment cuts, administrative burdens and mandatory participation in a new value-based model. Organizations including MGMA, NAACOS and Premier are calling on the agency to revise its plan. How Pharma Marketers Can Prepare for Trump's 200% Tariff Threat Putting aside the politics of this situation for the moment, here are some ways for commercial execs to navigate the current climate of volatility. Microplastics Are in Our Blood — Why Aren't Federal Regulators Acting? The longer we delay, the further we shift costs from polluters to patients — and to every taxpayer who funds Medicare, Medicaid and community hospitals. Environmental stewardship and human health are inseparable; regulating microplastics is preventive medicine on a national scale.

Video   OpenAI Announces Key Healthcare Hires OpenAI hired two key new leaders for its healthcare division. The first is Nate Gross, who is the company's head of health strategy. He is the co-founder of both Rock Health and Doximity. The other new hire is Ashley Alexander, who has joined OpenAI as vice president of health products. She comes to the company from Instagram, where she most recently served as co-head of product.

Sponsored The Top-Rated Suppliers of Lu-177 for Cancer Research Presented by SHINE Technologies With carrier-added and noncarrier-added versions available, the right supplier can make the difference between a program that stalls and one that successfully reaches patients. Learn More.

Resources

MedCity Pivot Podcast: Clinical Documentation Improvement With Smarter Technologies Smarter Technologies CEO Jeremy Delinsky explains how the company's AI infrastructure can help support health system's clinical documentation improvement efforts, ultimately strengthening RCM. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe